Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Optical genome and epigenome mapping of clear cell renal cell carcinoma

S. Margalit, Z. Tulpová, Y. Michaeli, TD. Zur, J. Deek, S. Louzoun-Zada, G. Nifker, A. Grunwald, Y. Scher, L. Schütz, E. Weinhold, Y. Gnatek, D. Omer, B. Dekel, E. Friedman, Y. Ebenstein

. 2025 ; 7 (1) : zcaf008. [pub] 20250307

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009544

Grantová podpora
R01 HG009190 NHGRI NIH HHS - United States

Cancer cells display complex genomic aberrations that include large-scale genetic rearrangements and epigenetic modulation that are not easily captured by short-read sequencing. This study presents a novel approach for simultaneous profiling of long-range genetic and epigenetic changes in matched cancer samples, focusing on clear cell renal cell carcinoma (ccRCC). ccRCC is a common kidney cancer subtype frequently characterized by a 3p deletion and the inactivation of the von Hippel-Lindau (VHL) gene. We performed integrated genetic, cytogenetic, and epigenetic analyses on paired tumor and adjacent nontumorous tissue samples. Optical genome mapping identified genomic aberrations as structural and copy number variations, complementing exome-sequencing findings. Single-molecule methylome and hydroxymethylome mapping revealed a significant global reduction in 5hmC level in both sample pairs, and a correlation between both epigenetic signals and gene expression was observed. The single-molecule epigenetic analysis identified numerous differentially modified regions, some implicated in ccRCC pathogenesis, including the genes VHL, PRCC, and PBRM1. Notably, pathways related to metabolism and cancer development were significantly enriched among these differential regions. This study demonstrates the feasibility of integrating optical genome and epigenome mapping for comprehensive characterization of matched tumor and adjacent tissue, uncovering both established and novel somatic aberrations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009544
003      
CZ-PrNML
005      
20250429135533.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/narcan/zcaf008 $2 doi
035    __
$a (PubMed)40061565
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Margalit, Sapir $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
245    10
$a Optical genome and epigenome mapping of clear cell renal cell carcinoma / $c S. Margalit, Z. Tulpová, Y. Michaeli, TD. Zur, J. Deek, S. Louzoun-Zada, G. Nifker, A. Grunwald, Y. Scher, L. Schütz, E. Weinhold, Y. Gnatek, D. Omer, B. Dekel, E. Friedman, Y. Ebenstein
520    9_
$a Cancer cells display complex genomic aberrations that include large-scale genetic rearrangements and epigenetic modulation that are not easily captured by short-read sequencing. This study presents a novel approach for simultaneous profiling of long-range genetic and epigenetic changes in matched cancer samples, focusing on clear cell renal cell carcinoma (ccRCC). ccRCC is a common kidney cancer subtype frequently characterized by a 3p deletion and the inactivation of the von Hippel-Lindau (VHL) gene. We performed integrated genetic, cytogenetic, and epigenetic analyses on paired tumor and adjacent nontumorous tissue samples. Optical genome mapping identified genomic aberrations as structural and copy number variations, complementing exome-sequencing findings. Single-molecule methylome and hydroxymethylome mapping revealed a significant global reduction in 5hmC level in both sample pairs, and a correlation between both epigenetic signals and gene expression was observed. The single-molecule epigenetic analysis identified numerous differentially modified regions, some implicated in ccRCC pathogenesis, including the genes VHL, PRCC, and PBRM1. Notably, pathways related to metabolism and cancer development were significantly enriched among these differential regions. This study demonstrates the feasibility of integrating optical genome and epigenome mapping for comprehensive characterization of matched tumor and adjacent tissue, uncovering both established and novel somatic aberrations.
650    _2
$a lidé $7 D006801
650    12
$a karcinom z renálních buněk $x genetika $x patologie $7 D002292
650    12
$a nádory ledvin $x genetika $x patologie $7 D007680
650    12
$a variabilita počtu kopií segmentů DNA $x genetika $7 D056915
650    12
$a epigeneze genetická $x genetika $7 D044127
650    12
$a epigenom $x genetika $7 D000081122
650    12
$a metylace DNA $x genetika $7 D019175
650    _2
$a nádorový supresorový protein VHL $x genetika $7 D051794
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mapování chromozomů $x metody $7 D002874
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a DNA vazebné proteiny $7 D004268
650    _2
$a transkripční faktory $7 D014157
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Tulpová, Zuzana $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel $u Institute of Experimental Botany of the Czech Academy of Sciences, 77900, Olomouc, Czech Republic $1 https://orcid.org/0000000244039367
700    1_
$a Michaeli, Yael $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Zur, Tahir Detinis $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Deek, Jasline $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Louzoun-Zada, Sivan $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Nifker, Gil $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Grunwald, Assaf $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Scher, Yuval $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Schütz, Leonie $u Institute of Organic Chemistry, RWTH Aachen University, D-52056 Aachen, Germany
700    1_
$a Weinhold, Elmar $u Institute of Organic Chemistry, RWTH Aachen University, D-52056 Aachen, Germany
700    1_
$a Gnatek, Yehudit $u Pediatric Stem Cell Research Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 52621 Ramat Gan, Israel
700    1_
$a Omer, Dorit $u Pediatric Stem Cell Research Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 52621 Ramat Gan, Israel
700    1_
$a Dekel, Benjamin $u Pediatric Stem Cell Research Institute, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 52621 Ramat Gan, Israel $u Pediatric Nephrology Unit, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, 52621 Ramat Gan, Israel $u School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, 6997801 Tel Aviv, Israel
700    1_
$a Friedman, Eitan $u School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, 6997801 Tel Aviv, Israel $u The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Sheba Medical Center, 52621 Ramat Gan, Israel
700    1_
$a Ebenstein, Yuval $u School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, 6997801 Tel Aviv, Israel $u Department of Biomedical Engineering, Tel Aviv University, 6997801 Tel Aviv, Israel $1 https://orcid.org/0000000271077529
773    0_
$w MED00209101 $t NAR cancer $x 2632-8674 $g Roč. 7, č. 1 (2025), s. zcaf008
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40061565 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135529 $b ABA008
999    __
$a ok $b bmc $g 2311123 $s 1246625
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 7 $c 1 $d zcaf008 $e 20250307 $i 2632-8674 $m NAR cancer $n NAR Cancer $x MED00209101
GRA    __
$a R01 HG009190 $p NHGRI NIH HHS $2 United States
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace